Kui Zhao
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 3
- Pharmacology top 5%
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 4
- Natural product bioactivities and synthesis 3
- RNA Research and Splicing 3
- Ginseng Biological Effects and Applications 2
Kui Zhao
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 336
- Complementary and alternative medicine 96
- Pharmacology 91
- Molecular Biology 651
- Oncology 161
Countries citing papers authored by Kui Zhao
This map shows the geographic impact of Kui Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Zhao more than expected).
Fields of papers citing papers by Kui Zhao
This network shows the impact of papers produced by Kui Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Zhao. The network helps show where Kui Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kui Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2022 | 10 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 27 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 47 | |
| 7 | 2021 | 70 | |
| 8 | 2020 | 30 | |
| 9 | 2019 | 52 | |
| 10 | 2018 | 24 | |
| 11 | 2016 | 17 | |
| 12 | 2015 | 78 | |
| 13 | 2014 | 6 | |
| 14 | 2014 | 28 | |
| 15 | 2013 | 16 | |
| 16 | Interventional Treatment for Elderly Advanced Primary Liver Cancer by Brucea javanica Oil Emulsion | 2011 | 1 |
| 17 | 2009 | 63 | |
| 18 | Inhibition of Gastric Carcinoma Lymphangiogenesis with Small Interfering RNA Against VEGF-C | 2008 | 1 |
| 19 | 2003 | 194 | |
| 20 | 1993 | 1 |
About Kui Zhao
Kui Zhao is a scholar working on Cancer Research, Molecular Biology and Toxicology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (3 papers), Natural product bioactivities and synthesis (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), RNA Research and Splicing (3 papers) and Ginseng Biological Effects and Applications (2 papers). The work is most often cited by research in Cancer Research (336 citations), Complementary and alternative medicine (96 citations) and Pharmacology (91 citations). Kui Zhao has collaborated with scholars based in China, Hong Kong and Japan. Frequent co-authors include Tina T. X. Dong, Karl Wah Keung Tsim, Yongyou Wu, Xiu Ming Cui, Zhao Ji, Chungen Xing, Yecheng Li, Yong Wu, Qiangbin Wang and Feng Hu. Their work appears in journals such as Advanced Materials, Molecular and Cellular Biology and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.